rs13429458 — THADA THADA PCOS/T2D Variant
Intronic variant in THADA, a gene encoding a calcium channel-regulating protein; the C allele increases PCOS risk in Asian women and influences pancreatic beta-cell function in the context of type 2 diabetes
Details
- Gene
- THADA
- Chromosome
- 2
- Risk allele
- C
- Clinical
- Risk Factor
- Evidence
- Moderate
Population Frequency
Category
Blood Sugar & DiabetesSee your personal result for THADA
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
THADA — Where Thyroid Adenomas, Diabetes, and PCOS Converge
THADA (thyroid adenoma associated) takes its name from a chromosomal translocation
breakpoint first identified in thyroid tumors — but the gene's most clinically
consequential story is in metabolic and reproductive medicine. THADA encodes a
large protein containing armadillo-type repeats that is thought to regulate
endoplasmic reticulum calcium homeostasis11 endoplasmic reticulum calcium homeostasis
The ER is the cell's calcium reservoir;
controlled release of Ca²⁺ from the ER into the cytosol drives insulin secretion
in beta cells and steroidogenesis in ovarian theca cells and to participate in
apoptotic signaling. Through these mechanisms, THADA variants influence how
pancreatic beta cells respond to glucose and how ovarian cells handle reproductive
hormone signaling.
The rs13429458 variant (A>C) sits within an intron of THADA on chromosome 2 at position 43,411,699 (GRCh38). It does not change any amino acid, but intronic variants in this region are thought to alter THADA expression levels, modulating the functional output of the gene in metabolically active tissues. The C allele is the minor allele globally (~12.2%), but reaches ~21.8% frequency in East Asian populations, explaining the pronounced ethnic differences in its effects.
The Mechanism
THADA's role in ER calcium regulation is central to understanding why this variant
surfaces in both diabetes and PCOS GWAS. In pancreatic beta cells, ER calcium
release is a critical trigger for insulin exocytosis; altered THADA function
could blunt the beta-cell response to secretagogues like GLP-1 and arginine.
Simonis-Bik and colleagues22 Simonis-Bik and colleagues
Simonis-Bik AMC et al. Gene variants in the novel
type 2 diabetes loci affect different aspects of pancreatic beta-cell function.
Diabetes, 2010 demonstrated that
the THADA locus specifically associated with a lower beta-cell response to
GLP-1 stimulation and to arginine — a secretagogue that bypasses glucose metabolism
— pointing to a defect in the calcium-dependent secretory machinery rather than
in glucose sensing itself.
In ovarian tissue, THADA may modulate apoptotic signaling in granulosa and theca cells. Disrupted ER calcium handling has been linked to insulin resistance and androgen excess — hallmarks of PCOS. The precise molecular pathway from rs13429458 genotype to PCOS phenotype remains under investigation, but the GWAS signal is robust in Asian populations and the mechanistic hypothesis is coherent.
The Evidence
THADA was first implicated in type 2 diabetes by the influential
Zeggini et al. meta-analysis33 Zeggini et al. meta-analysis
Zeggini E et al. Meta-analysis of genome-wide
association data and large-scale replication identifies additional susceptibility
loci for type 2 diabetes. Nat Genet, 2008,
which identified the THADA region at genome-wide significance (p=1.1×10⁻⁹) in
a combined discovery and replication sample of over 64,000 European-ancestry
individuals.
For PCOS, a
systematic review and meta-analysis44 systematic review and meta-analysis
Park S et al. THADA_rs13429458 Minor Allele
Increases the Risk of Polycystic Ovary Syndrome in Asian, but Not in Caucasian
Women. Horm Metab Res, 2019
pooling 38,224 cases and 120,173 controls across 10 studies established that the
C allele carries a significant PCOS risk in Asian women — OR 1.24 in the allelic
model, OR 1.70 in the dominant model — but showed no significant effect in
Caucasian women. This ethnic specificity aligns with the higher C-allele frequency
in East Asian populations.
In Han Chinese women with PCOS,
Tian et al.55 Tian et al.
Tian Y et al. PCOS-GWAS Susceptibility Variants in THADA, INSR,
TOX3, and DENND1A Are Associated With Metabolic Syndrome or Insulin Resistance.
Front Endocrinol, 2020 found rs13429458
was significantly associated with insulin resistance, linking the diabetes-PCOS
overlap directly to this variant. A
Chinese case-control study66 Chinese case-control study
Wan P et al. Replication study and meta-analysis of
selected genetic variants and polycystic ovary syndrome susceptibility in Asian
population. J Assist Reprod Genet, 2021
of 400 cases and 480 controls replicated this association, with significance surviving
Bonferroni correction.
In Indian women with PCOS,
Dadachanji et al.77 Dadachanji et al.
Dadachanji R et al. Replication study of THADA rs13429458
variant with PCOS susceptibility and its related traits in Indian women.
Gynecol Endocrinol, 2021 found
that C allele carriers showed reduced fasting glucose and lower free testosterone,
suggesting the variant may modulate PCOS severity even in populations where it
does not alter PCOS susceptibility.
Evidence quality is moderate: the T2D signal is well-replicated across European cohorts; the PCOS signal is strong in Asian women but inconsistent in Europeans and South Asians. The biological mechanism linking this intronic variant to altered THADA expression is plausible but not yet directly demonstrated.
Practical Actions
For heterozygous and homozygous C-allele carriers, the principal actionable concern is metabolic vigilance: THADA variants affect GLP-1-stimulated insulin secretion and are associated with insulin resistance in the context of PCOS. Optimizing insulin sensitivity through diet composition — specifically, reducing dietary glycemic load to lessen demand on beta cells with potentially blunted secretory capacity — is the most evidence-supported intervention.
For women, particularly those of Asian ancestry, the PCOS connection warrants attention to menstrual regularity, androgen levels, and ovarian morphology. A PCOS evaluation is appropriate if symptoms are present.
Inositol supplementation (specifically myo-inositol, which acts as a second messenger in insulin signaling) has shown benefit specifically in insulin-resistant PCOS, with effects on both insulin sensitivity and ovarian function. This represents a mechanism-targeted intervention for C-allele carriers.
Interactions
The most relevant genetic interaction is with INSR rs2059807, which tags insulin receptor function. Both rs13429458 in THADA and rs2059807 in INSR associate with insulin resistance in PCOS [Tian et al. 2020], and individuals carrying risk alleles at both loci are likely to have compounded metabolic risk. The THADA variant (impairing beta-cell secretory response) combined with an INSR variant (impairing peripheral insulin signaling) could create a mutually reinforcing insulin resistance phenotype.
THADA rs7578597 is the primary T2D-associated missense variant in the same gene (Thr>Ala), and was identified in a separate GWAS; rs13429458 is the PCOS GWAS lead. The two are in the same gene but tag somewhat different phenotypic domains, making it worth tracking both.
Genotype Interpretations
What each possible genotype means for this variant:
Two copies of the common allele — standard THADA function
You carry two copies of the A allele at rs13429458, the most common genotype globally — approximately 77% of people worldwide share it. This genotype is associated with normal THADA expression and no elevated risk for PCOS or type 2 diabetes through this locus.
Your beta-cell response to GLP-1 and arginine stimulation is expected to be unaffected by this variant. No specific action is required beyond routine metabolic health maintenance.
One copy of the risk allele — mildly elevated PCOS and metabolic risk, especially in Asian ancestry
The heterozygous AC genotype produces an intermediate THADA expression phenotype. In the Park et al. 2019 meta-analysis of 10 studies, heterozygotes showed an OR of approximately 1.34 for PCOS in Asian populations. The Simonis-Bik et al. (2010) beta-cell study found that the THADA locus influences GLP-1-stimulated insulin secretion, a mechanism that could predispose to both T2D and the metabolic features of PCOS.
The Dadachanji et al. (2021) study of Indian women found that C-allele carriers within the PCOS population had lower fasting glucose and testosterone levels — suggesting the variant may modulate PCOS severity even where it doesn't change susceptibility, adding nuance to the clinical picture.
Two copies of the risk allele — elevated PCOS susceptibility in Asian women and potentially reduced GLP-1-driven insulin secretion
The Park et al. (2019) meta-analysis across 38,224 PCOS cases and 120,173 controls established an OR of 1.71 for the CC homozygous genotype in the homozygous model in Asian women. The Wan et al. (2021) replication in Chinese women confirmed the association after Bonferroni correction.
Simonis-Bik et al. (2010) linked the THADA locus specifically to reduced GLP-1 and arginine-stimulated insulin secretion — secretagogues that act via the calcium-dependent pathway — consistent with a role for THADA in ER calcium handling within beta cells. The Tian et al. (2020) study in 2,082 Han Chinese women with PCOS found rs13429458 significantly associated with insulin resistance in this population.
In the Zeggini et al. (2008) T2D GWAS, the THADA region reached p=1.1×10⁻⁹, confirming robust involvement in diabetes susceptibility in European populations as well, through a somewhat distinct phenotypic mechanism.
THADA's parent-of-origin effects also deserve note: the nearby missense variant rs7578597 shows excess maternal transmission to T2D offspring, raising the possibility that THADA-region variants have epigenetic imprinting effects that modulate transmission of metabolic risk.